Stacey E. P. Joosten

719 total citations
9 papers, 184 citations indexed

About

Stacey E. P. Joosten is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Stacey E. P. Joosten has authored 9 papers receiving a total of 184 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Cancer Research. Recurrent topics in Stacey E. P. Joosten's work include Genomics and Chromatin Dynamics (4 papers), Estrogen and related hormone effects (3 papers) and Epigenetics and DNA Methylation (2 papers). Stacey E. P. Joosten is often cited by papers focused on Genomics and Chromatin Dynamics (4 papers), Estrogen and related hormone effects (3 papers) and Epigenetics and DNA Methylation (2 papers). Stacey E. P. Joosten collaborates with scholars based in Netherlands, United States and United Kingdom. Stacey E. P. Joosten's co-authors include Wilbert Zwart, Sabine C. Linn, Yongsoo Kim, Valesca P. Retèl, Wim H. van Harten, Veerle M.H. Coupé, Michel M. van den Heuvel, Tesa Severson, Geoffrey L. Greene and Petra van der Groep and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Genome Research.

In The Last Decade

Stacey E. P. Joosten

8 papers receiving 182 citations

Peers

Stacey E. P. Joosten
Shannon A. Slater United States
Valentina Scabia Switzerland
Pavana Anur United States
Laura Battista Switzerland
Courtney L. Andersen United States
Shannon A. Slater United States
Stacey E. P. Joosten
Citations per year, relative to Stacey E. P. Joosten Stacey E. P. Joosten (= 1×) peers Shannon A. Slater

Countries citing papers authored by Stacey E. P. Joosten

Since Specialization
Citations

This map shows the geographic impact of Stacey E. P. Joosten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stacey E. P. Joosten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stacey E. P. Joosten more than expected).

Fields of papers citing papers by Stacey E. P. Joosten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stacey E. P. Joosten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stacey E. P. Joosten. The network helps show where Stacey E. P. Joosten may publish in the future.

Co-authorship network of co-authors of Stacey E. P. Joosten

This figure shows the co-authorship network connecting the top 25 collaborators of Stacey E. P. Joosten. A scholar is included among the top collaborators of Stacey E. P. Joosten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stacey E. P. Joosten. Stacey E. P. Joosten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
2.
Manzo, Stefano Giustino, Stefan Preković, Tom van Schaik, et al.. (2023). Perturbations in 3D genome organization can promote acquired drug resistance. Cell Reports. 42(10). 113124–113124. 9 indexed citations
3.
Krenning, Lenno, Tesa Severson, Xabier Vergara, et al.. (2022). Double-strand break toxicity is chromatin context independent. Nucleic Acids Research. 50(17). 9930–9947. 16 indexed citations
4.
Joosten, Stacey E. P., Rutger H.T. Koornstra, Annelot van Rossum, et al.. (2021). IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women. npj Breast Cancer. 7(1). 138–138. 2 indexed citations
5.
Kastrati, Irida, Stacey E. P. Joosten, Svetlana E. Semina, et al.. (2020). The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor–Positive Breast Cancers. Molecular Cancer Research. 18(7). 1018–1027. 38 indexed citations
7.
Osako, Tomo, Hakwoo Lee, Gulisa Turashvili, et al.. (2020). Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effects. Nature Cancer. 1(5). 518–532. 13 indexed citations
8.
Severson, Tesa, Yongsoo Kim, Stacey E. P. Joosten, et al.. (2018). Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer. Nature Communications. 9(1). 482–482. 51 indexed citations
9.
Joosten, Stacey E. P., Valesca P. Retèl, Veerle M.H. Coupé, Michel M. van den Heuvel, & Wim H. van Harten. (2016). Scenario drafting for early technology assessment of next generation sequencing in clinical oncology. BMC Cancer. 16(1). 66–66. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026